CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Triple-Drug attack on blood cancer shows promise
Disease control OngoingThis study is testing whether a combination of three drugs—acalabrutinib, venetoclax, and obinutuzumab—is a safe and effective first treatment for chronic lymphocytic leukemia (CLL). The trial involves 72 adults with CLL who have not had prior treatment but need it based on their…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Cancer treatment break: study tests stopping pills when disease disappears
Disease control OngoingThis study is testing whether people with chronic lymphocytic leukemia or small lymphocytic lymphoma can safely stop their venetoclax treatment when blood tests show no detectable cancer cells. Researchers will follow 81 patients who stop treatment to see if they remain cancer-fr…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug combo tested to control blood cancer in First-Time patients
Disease control OngoingThis study is testing how well a combination of two drugs, venetoclax and obinutuzumab, works for people with chronic lymphocytic leukemia (CLL) who have not yet received any treatment. It aims to see if this combination can control the cancer and delay its progression. The trial…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC